Sophie Ugolini, winner of the Impulscience® program of the Bettencourt Schueller Foundation

The Impulscience® program aims to reward and support outstanding researchers in France. This program supports researchers to improve our knowledge of living organisms and ultimately human health.

Sophie Ugolini, researcher in Immunology, research director at Inserm and head of the "Neuronal regulation of immunity" team at the Marseille-Luminy Immunology Center (CIML), is a winner of the 2023 program for her work on the interactions between the nervous system and the immune system.
Her team is seeking to understand the mechanisms by which the nervous system and the immune system work together to repair tissue damage, particularly in the skin, and to defend against infections.

More information
Watch the video

Eric Vivier and Bernard Malissen, among the highest cited researchers in the world

Eric VIVIER and Bernard MALISSEN, team leaders at the Marseille-Luminy Immunology Center, are on the 2023 list of the most cited researchers in the world for the eighth time, as in previous editions 2016, 2017, 2018, 2019, 2020, 2021 and 2022.
Published annually by the prestigious Clarivate Analytics Company, previously Thomson Reuters, this ranking recognizes authors of the most frequently cited publications in the scientific community.
A recognition mark that rewards the value of their discoveries and the exceptional research influence in their scientific field.

See the list

The CIML is proud to announce the selection of two new team leaders

The CIML is proud to announce the selection of two new team leaders through our recent competitive international call: Romain Roncagalli and Thomas Dupic.

Thomas Dupic is a postdoctoral fellow in the lab of Michael Desai at Harvard. He is an expert in mathematical physics and developed high throughput quantitative methods to interrogate the human B and T cell repertoire. He will lead the “Affinities in the adaptive repertoire” laboratory.

Romain Roncagalli is Research Director at CNRS, currently working in the team of Bernard and Marie Malissen at CIML. He is an internationally recognized expert in the study of TCR signaling through quantitative proteomic approaches. He will lead the “Integrative biology of T cells” laboratory.

ERC Synergy Grant 2023 for Immunotherapy of liver metastases

The CIML is proud to announce that Prof. Eric Vivier is one of the recipients of the highly competitive and generously funded Synergy Grant from the European Research Council (ERC)

Together with Valeria Fumagalli (San Raffaele Hospital, Italy), Georg Gasteiger (Max Planck Research Group at the University of Würzburg), Florent Ginhoux (Gustave Roussy Cancer Campus, France), they will explore new avenues for immunotherapy of liver metastases – a condition that affects approximately half of all cancer patients.
This ERC Synergy Grant is the fourth European Research Council grant won by Prof. Eric Vivier's team. They had already won two ERC Advanced Grants in 2010 and 2015, as well as an ERC Proof of Concept in 2019.
Press release

Strengthening the weakened immune system: an unusual weapon against cytomegalovirus

In a recent publication in the journal EMBO Molecular Medicine, researchers introduce an innovative approach to safeguard immunocompromised patients from cytomegalovirus (CMV)

While these infections are generally harmless to most individuals, they become life-threatening for those with weakened immune systems. Instead of relying on antiviral drugs, this method focuses on fortifying the compromised immune system, empowering it to combat the virus independently.
More information